Denmark· DK-28107180124

Epruvy

A ranibizumab product containing ranibizumab, registered in Denmark by Midas Pharma. The same ATC class is registered in 15 of our 19 countries.

ATC S01LA04

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedEpruvyATCS01LA04REGISTER NO.DK-28107180124PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Ranibizumab is registered in 15 of 19 countries.

Countries holding a registration under ATC S01LA04 (ranibizumab), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 9 of them publish a price we can compare per daily dose

Ranibizumab · ATC S01LA04

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
Ranibizumab
Manufacturer
Midas Pharma
Country
Denmark (DK)
ATC code
S01LA04
ATC class
Ranibizumab
Defined daily dose
0.036 DE, IVT
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28107180124

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ca0c839d-12f9-4b49-b319-c6218db65346
GET /v1/drugs/ca0c839d-12f9-4b49-b319-c6218db65346?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "injektionsvæske, opløsning",
  "source": "dkma",
  "strength": "10 mg/ml",
  "auth_role": "MOD",
  "dk_drugid": "28107180124",
  "substance": "Ranibizumab",
  "auth_procedure": "Central",
  "in_medicinpriser": false,
  "registration_date_serial": "45554"
}

See everything about ranibizumab.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.